# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-094732
Filing Date
2024-08-09
Accepted
2024-08-09 16:03:47
Documents
64
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | prok-20240630.htm iXBRL | 10-Q | 1921996
2 | EX-31.1 | prok-ex31_1.htm | EX-31.1 | 16515
3 | EX-31.2 | prok-ex31_2.htm | EX-31.2 | 16497
4 | EX-32.1 | prok-ex32_1.htm | EX-32.1 | 9436
5 | EX-32.2 | prok-ex32_2.htm | EX-32.2 | 9449
| Complete submission text file | 0000950170-24-094732.txt |  | 8151044

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | prok-20240630.xsd | EX-101.SCH | 1211008
66 | EXTRACTED XBRL INSTANCE DOCUMENT | prok-20240630_htm.xml | XML | 1478703

Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40560 | Film No.: 241192501
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)